跳至主要内容
临床试验/NCT03505177
NCT03505177已完成不适用

Characterization of the Gut Microbiota Composition and Activity After Three Weeks of Chitin-glucan Supplementation

Nathalie Delzenne2 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2018年4月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
17
试验地点
2
主要终点
Gut microbiota composition

研究概览

简要总结

The aim of this research study is to characterize gut microbiota composition and activity after a daily supplementation of 4.5 g of chitin-glucan during 3 weeks. For this purpose, a monocentric longitudinal intervention study without control will be performed. Fecal microbiota composition and fecal concentrations of gut microbiota-derived metabolites (bile acids, conjugated-polyunsaturated fatty acids and short-chain fatty acids) will be measured. In addition, during ten hours following the ingestion of a test meal rich in fibers, the kinetic of production of H2, methane and volatile compounds exhaled from breath will be evaluated.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Woman or man, aged of 18 to 40 years
  • Body mass index (BMI) between 18 and 25 kg/m2
  • In good general health as evidenced by medical history and physical examination
  • Non-smoker
  • Caucasian
  • H2 - producer
  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study

排除标准

  • Subjects presenting gastro-intestinal disorders such as ulcers, diverticulitis and inflammatory bowel diseases
  • Subject presenting allergy or food intolerance (lactose, gluten,...)
  • Subjects with psychiatric problems and/or using antipsychotics
  • Current or recent (< 4 weeks) intake of antibiotic, probiotic, prebiotic, fiber supplement, and/or any product modulating gut transit
  • Feeding particular diet such as vegetarian diet or hyper protein diet
  • Chronic intake of drug, excepted contraceptive drug
  • Pregnant or lactating woman or woman who did not use highly effective contraception
  • Subjects who drink more than 3 glasses of alcohol per day (> 30 g of alcohol per day)
  • Subjects having participated to another clinical trial two weeks before the screening test visit
  • Subjects presenting an allergy or intolerance to one component of the product tested

研究组 & 干预措施

Chitin-glucan

Experimental

Supplementation during 3 weeks with 4.5g per day of chitin-glucan fiber

干预措施: Chitin-glucan fiber (Dietary Supplement)

结局指标

主要结局

Gut microbiota composition

时间窗: Difference between day 0 and day 21

Illumina sequencing of 16SrDNA

次要结局

  • Fecal short-chain fatty acids(Difference between day 0 and day 21)
  • Fecal bile acids(Difference between day 0 and day 21)
  • Exhaled acetate(Difference between day 0 and day 21)
  • Fecal conjugated-linoleic acids(Difference between day 0 and day 21)
  • Exhaled propionate(Difference between day 0 and day 21)
  • Exhaled H2S(Difference between day 0 and day 21)
  • Exhaled CH4(Difference between day 0 and day 21)
  • Exhaled H2(Difference between day 0 and day 21)
  • Gastro-intestinal symptom - nausea(Difference between Day 0 and Day 21)
  • Exhaled butyrate(Difference between day 0 and day 21)
  • Exhaled C2(Difference between day 0 and day 21)
  • Exhaled CO2(Difference between day 0 and day 21)
  • Exhaled O2(Difference between day 0 and day 21)
  • Exhaled CO(Difference between day 0 and day 21)
  • Gastro-intestinal symptom - flatulences(Difference between Day 0 and Day 21)
  • Gastro-intestinal symptom - gastrointestinal reflux(Difference between Day 0 and Day 21)
  • Exhaled N2(Difference between day 0 and day 21)
  • Exhaled volatile compounds(Difference between day 0 and day 21)
  • Gastro-intestinal symptom - discomfort(Difference between Day 0 and Day 21)
  • Gastro-intestinal symptom - cramps(Difference between Day 0 and Day 21)
  • Gastro-intestinal symptom - rumbling(Difference between Day 0 and Day 21)
  • Gastro-intestinal symptom - burps(Difference between Day 0 and Day 21)
  • Gastro-intestinal symptom - bloating(Difference between Day 0 and Day 21)

研究者

发起方
Nathalie Delzenne
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Nathalie Delzenne

Professor

Université Catholique de Louvain

研究点 (2)

Loading locations...

相似试验